This research investigated the relationship between physical activity and cardiovascular outcomes in adults with metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States. The study utilized data from the 2003-2006 US National Health and Nutrition Examination Survey, tracking mortality through December 2019. HSI was primarily defined using the Hepatic Steatosis Index (HSI), with sensitivity analyses employing the US Fatty Liver Index (USFLI).
Key Clinical Findings
A total of 2785 individuals with HSI-defined MASLD were included in the analysis, experiencing 584 deaths, including 198 cardiovascular deaths over a median follow-up of 14.7 years. Results indicated a non-linear association between increasing moderate-to-vigorous physical activity (MVPA) and reduced all-cause mortality. Specifically, an increase of 10 minutes in MVPA was associated with a hazard ratio of 0.80 (95% CI: 0.71-0.91, P < 0.001). Similarly, higher MVPA was associated with a lower risk of cardiovascular mortality in MASLD, with a hazard ratio of 0.72 (95% CI: 0.53-0.99, P = 0.009). Total physical activity showed a weaker association with mortality compared to MVPA. Increased sedentary behavior did not impact mortality in the MASLD group.